Aberrant Notch signaling in gliomas: a potential landscape of actionable converging targets for combination approach in therapies resistance

Abstract

The current therapeutic protocols and prognosis of gliomas still depend on clinicopathologic and radiographic characteristics. For high-grade gliomas, the standard of care is resection followed by radiotherapy plus temozolomide chemotherapy. However, treatment resistance develops due to different mechanisms, among which is the dynamic interplay between the tumor and its microenvironment. Different signaling pathways cause the proliferation of so-called glioma stem cells, a minor cancer cell population with stem cell-like characteristics and aggressive phenotype. In the last decades, numerous studies have indicated that Notch is a crucial pathway that maintains the characteristics of resistant glioma stem cells. Data obtained from preclinical models indicate that downregulation of the Notch pathway could induce multifaceted drug sensitivity, acting on the expression of drug-transporter proteins, inducing epithelial–mesenchymal transition, and shaping the tumor microenvironment. This review provides a brief overview of the published data supporting the roles of Notch in drug resistance and demonstrates how potential novel strategies targeting Notch could become an efficacious action to improve the therapy of high-grade glioma to overcome drug resistance.

Keywords

Tumor microenvironment / notch inhibitors / stem cells / brain tumors / drug resistance

References

[1] Louis DN,Wesseling P.The 2021 WHO classification of tumors of the central nervous system: a summary.Neuro Oncol2021;23:1231-51 PMCID:PMC8328013

[2] Louis DN,Reifenberger G.The 2016 World Health Organization classification of tumors of the central nervous system: a summary.Acta Neuropathol2016;131:803-20

[3] Feldheim J,Monoranu CM,Löhr M.Changes of O⁶-Methylguanine DNA Methyltransferase (MGMT) promoter methylation in glioblastoma relapse-a meta-analysis type literature review.Cancers (Basel)2019;11:1837 PMCID:PMC6966671

[4] Indraccolo S,Fassan M.Genetic, epigenetic, and immunologic profiling of MMR-deficient relapsed glioblastoma.Clin Cancer Res2019;25:1828-37

[5] Du Z,Kim S.Structure-function analysis of oncogenic EGFR Kinase Domain Duplication reveals insights into activation and a potential approach for therapeutic targeting.Nat Commun2021;12:1382 PMCID:PMC7925532

[6] Smith JS,Qian J.Amplification of the platelet-derived growth factor receptor-A (PDGFRA) gene occurs in oligodendrogliomas with grade IV anaplastic features.J Neuropathol Exp Neurol2000;59:495-503

[7] Jiang T,Liu Y.Development of small-molecule tropomyosin receptor kinase (TRK) inhibitors for NTRK fusion cancers.Acta Pharmaceutica Sinica B2021;11:355-72 PMCID:PMC7893124

[8] Curry RN.The role of neurodevelopmental pathways in brain tumors.Front Cell Dev Biol2021;9:659055 PMCID:PMC8127784

[9] Artavanis-Tsakonas S,Lake RJ.Notch signaling: cell fate control and signal integration in development.Science1999;284:770-6

[10] Engler A,Taylor V.Notch and neurogenesis.Adv Exp Med Biol2018;1066:223-34

[11] Majumder S,Golde TE,Osborne BA.Targeting Notch in oncology: the path forward.Nat Rev Drug Discov2021;20:125-44

[12] Liu Z,Varnum-Finney B.The intracellular domains of Notch1 and Notch2 are functionally equivalent during development and carcinogenesis.Development2015;142:2452-63 PMCID:PMC4510869

[13] Aster JC,Blacklow SC.The varied roles of Notch in cancer.Annu Rev Pathol2017;12:245-75 PMCID:PMC5933931

[14] Lovschall H,Poulsen K,Kjeldsen AL.Coexpression of Notch3 and Rgs5 in the pericyte-vascular smooth muscle cell axis in response to pulp injury.Int J Dev Biol2007;51:715-21

[15] Carrieri FA.Turn it down a Notch.Front Cell Dev Biol2016;4:151 PMCID:PMC5241280

[16] Bray SJ.Notch signalling in context.Nat Rev Mol Cell Biol2016;17:722-35

[17] Wu L,Blacklow SC,Artavanis-Tsakonas S.MAML1, a human homologue of Drosophila mastermind, is a transcriptional co-activator for NOTCH receptors.Nat Genet2000;26:484-9

[18] Ramaiah MJ,Manyam RR.Epigenetic modulation and understanding of HDAC inhibitors in cancer therapy.Life Sci2021;277:119504

[19] Krishna BM,Singhal J.Notch signaling in breast cancer: from pathway analysis to therapy.Cancer Lett2019;461:123-31 PMCID:PMC9003668

[20] Montalto FI,Chiodo C.Progesterone receptor b signaling reduces breast cancer cell aggressiveness: role of cyclin-D1/Cdk4 mediating paxillin phosphorylation.Cancers (Basel)2019;11:1201 PMCID:PMC6721542

[21] Casimiro MC,Crosariol M.Kinase-independent role of cyclin D1 in chromosomal instability and mammary tumorigenesis.Oncotarget2015;6:8525-38 PMCID:PMC4496164

[22] Saiki W,Okajima T.Current views on the roles of O-Glycosylation in controlling notch-ligand interactions.Biomolecules2021;11:309 PMCID:PMC7922208

[23] Bertrand FE.The cross-talk of NOTCH and GSK-3 signaling in colon and other cancers.Biochim Biophys Acta Mol Cell Res2020;1867:118738

[24] Tabatabai G.Glioblastoma: state of the art and future perspectives.Cancers (Basel)2019;11:1091 PMCID:PMC6721299

[25] Wang L,Zhu S et al.Delta/notch-like epidermal growth factor-related receptor (DNER) orchestrates stemness and cancer progression in prostate cancer.Am J Transl Res2017;9:5031-9 PMCID:PMC5714787

[26] Sharma A,Galande S.Epigenetic regulation of the Wnt/β-catenin signaling pathway in cancer.Front Genet2021;12:681053 PMCID:PMC8450413

[27] Luo K.Signaling cross talk between TGF-β/Smad and other signaling pathways.Cold Spring Harb Perspect Biol2017;9:a022137 PMCID:PMC5204325

[28] Francesco EM, Maggiolini M, Musti AM. Crosstalk between Notch, HIF-1α and GPER in breast cancer EMT.Int J Mol Sci2018;19:2011 PMCID:PMC6073901

[29] Vinson KE,Fender AW,Sigounas G.The Notch pathway in colorectal cancer.Int J Cancer2016;138:1835-42

[30] Mollen EWJ,Tjan-Heijnen VCG.Moving breast cancer therapy up a Notch.Front Oncol2018;8:518 PMCID:PMC6256059

[31] Kwon OJ,Wang J.Notch promotes tumor metastasis in a prostate-specific Pten-null mouse model.J Clin Invest2016;126:2626-41 PMCID:PMC4922719

[32] Iglesias V, Giuranno L, Dubois LJ, Theys J, Vooijs M. Drug resistance in non-small cell lung cancer: a potential for NOTCH targeting?.Front Oncol2018;8:267 PMCID:PMC6066509

[33] Bazzoni R.Role of notch signaling pathway in glioblastoma pathogenesis.Cancers (Basel)2019;11:292 PMCID:PMC6468848

[34] Gersey Z,Bloom L.Therapeutic targeting of the Notch pathway in glioblastoma multiforme.World Neurosurg2019;131:252-263.e2

[35] Kulic I,Chang L.Loss of the notch effector RBPJ promotes tumorigenesis.J Exp Med2015;212:37-52 PMCID:PMC4291530

[36] Dotto GP.Notch tumor suppressor function.Oncogene2008;27:5115-23 PMCID:PMC2747622

[37] Fukusumi T.The NOTCH pathway in head and neck squamous cell carcinoma.J Dent Res2018;97:645-53 PMCID:PMC5960881

[38] Xiu MX,Kuang BH.The oncogenic role of Jagged1/Notch signaling in cancer.Biomed Pharmacother2020;129:110416

[39] Zhu H,Redfield S et al.Elevated jagged-1 and notch-1 expression in high grade and metastatic prostate cancers.Am J Transl Res2013;5:368-78 PMCID:PMC3633979

[40] Shi TP,Wei JF.Association of low expression of notch-1 and jagged-1 in human papillary bladder cancer and shorter survival.J Urol2008;180:361-6

[41] Aburjania Z,Whitt J,Chen H.The role of notch3 in cancer.Oncologist2018;23:900-11 PMCID:PMC6156186

[42] Yeasmin S,Rahman MT.Expression of nuclear Notch3 in cervical squamous cell carcinomas and its association with adverse clinical outcomes.Gynecol Oncol2010;117:409-16

[43] Lu QR,Zhou X.Developmental origins and oncogenic pathways in malignant brain tumors.Wiley Interdiscip Rev Dev Biol2019;8:e342 PMCID:PMC6565468

[44] Oldrini B,Squatrito M.Take it down a NOTCH in forebrain tumors.Cancer Cell2015;28:681-2

[45] Phillips HS,Chen R.Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis.Cancer Cell2006;9:157-73

[46] De Amicis F,Santoro M.A novel functional interplay between Progesterone Receptor-B and PTEN, via AKT, modulates autophagy in breast cancer cells.J Cell Mol Med2014;18:2252-65 PMCID:PMC4224558

[47] Parmigiani E,Giachino C.Oncogenic and tumor-suppressive functions of NOTCH signaling in glioma.Cells2020;9:2304 PMCID:PMC7602630

[48] Xing ZY,Guo WJ.Elevated expression of Notch-1 and EGFR induced apoptosis in glioblastoma multiforme patients.Clin Neurol Neurosurg2015;131:54-8

[49] Noor H,McDonald KL.DLL3 expression and methylation are associated with lower-grade glioma immune microenvironment and prognosis.Genomics2022;114:110289

[50] Cheng L,Zhou W.Glioblastoma stem cells generate vascular pericytes to support vessel function and tumor growth.Cell2013;153:139-52 PMCID:PMC3638263

[51] Gimple RC,Dixit D.Glioblastoma stem cells: lessons from the tumor hierarchy in a lethal cancer.Genes Dev2019;33:591-609 PMCID:PMC6546059

[52] Biserova K,Uljanovs R.Cancer stem cells: significance in origin, pathogenesis and treatment of glioblastoma.Cells2021;10:621 PMCID:PMC8000844

[53] Passaro AP,Yao Y.Immune response in neurological pathology: emerging role of central and peripheral immune crosstalk.Front Immunol2021;12:676621 PMCID:PMC8222736

[54] Touat M,Sanson M.Glioblastoma targeted therapy: updated approaches from recent biological insights.Ann Oncol2017;28:1457-72 PMCID:PMC5834086

[55] Garner JM,Finkelstein D.Molecular heterogeneity in a patient-derived glioblastoma xenoline is regulated by different cancer stem cell populations.PLoS ONE2015;10:e0125838

[56] Yabo YA,Golebiewska A.Cancer cell heterogeneity and plasticity: a paradigm shift in glioblastoma.Neuro Oncol2022;24:669-82 PMCID:PMC9071273

[57] Zhang C,Gao F et al.Wild-type TP53 defined gamma-secretase inhibitor sensitivity and synergistic activity with doxorubicin in GSCs.Am J Cancer Res2019;9:1734-45 PMCID:PMC6726980

[58] Jiang X,Kim TM.Numb regulates glioma stem cell fate and growth by altering epidermal growth factor receptor and Skp1-Cullin-F-box ubiquitin ligase activity.Stem Cells2012;30:1313-26 PMCID:PMC3963835

[59] Qiang L,Zhang HW.HIF-1α is critical for hypoxia-mediated maintenance of glioblastoma stem cells by activating Notch signaling pathway.Cell Death Differ2012;19:284-94 PMCID:PMC3263503

[60] Ojha R,Rimal S,Cheshier S.Regulation of reverse electron transfer at mitochondrial complex I by unconventional Notch action in cancer stem cells.Dev Cell2022;57:260-276.e9 PMCID:PMC8852348

[61] Pinto G,Chastagner P.Patient-derived glioblastoma stem cells transfer mitochondria through tunneling nanotubes in tumor organoids.Biochem J2021;478:21-39 PMCID:PMC7800365

[62] Bao S,McLendon RE.Glioma stem cells promote radioresistance by preferential activation of the DNA damage response.Nature2006;444:756-60

[63] Alafate W,Wu W.Loss of PLK2 induces acquired resistance to temozolomide in GBM via activation of notch signaling.J Exp Clin Cancer Res2020;39:239 PMCID:PMC7657349

[64] Negri FV,Pedrazzi G.Strong Notch activation hinders bevacizumab efficacy in advanced colorectal cancer.Future Oncol2015;11:3167-74

[65] Meng RD,Li YM.gamma-Secretase inhibitors abrogate oxaliplatin-induced activation of the Notch-1 signaling pathway in colon cancer cells resulting in enhanced chemosensitivity.Cancer Res2009;69:573-82 PMCID:PMC3242515

[66] Roberts NB,Hwang JR.Oxaliplatin disrupts pathological features of glioma cells and associated macrophages independent of apoptosis induction.J Neurooncol2018;140:497-507 PMCID:PMC6580860

[67] Cho S,He X.Notch1 regulates the expression of the multidrug resistance gene ABCC1/MRP1 in cultured cancer cells.Proc Natl Acad Sci U S A2011;108:20778-83 PMCID:PMC3251103

[68] Fan X,Zhu TS.NOTCH pathway blockade depletes CD133-positive glioblastoma cells and inhibits growth of tumor neurospheres and xenografts.Stem Cells2010;28:5-16 PMCID:PMC2878196

[69] Wang YC,Feng F.Notch signaling determines the M1 versus M2 polarization of macrophages in antitumor immune responses.Cancer Res2010;70:4840-9

[70] Sarkar S,Zemp FJ.Activation of NOTCH signaling by tenascin-C promotes growth of human brain tumor-initiating cells.Cancer Res2017;77:3231-43

[71] Kološa K,Herold-Mende C,Lah TT.Paracrine effects of mesenchymal stem cells induce senescence and differentiation of glioblastoma stem-like cells.Cell Transplant2015;24:631-44

[72] Fedele M,Pegoraro S,Manfioletti G.Proneural-mesenchymal transition: phenotypic plasticity to acquire multitherapy resistance in glioblastoma.Int J Mol Sci2019;20:2746 PMCID:PMC6600373

[73] Guelfi S,Deleuze V.SLUG and truncated TAL1 reduce glioblastoma stem cell growth downstream of notch1 and define distinct vascular subpopulations in glioblastoma multiforme.Cancers (Basel)2021;13:5393 PMCID:PMC8582547

[74] Kristoffersen K,Villingshøj M.Inhibition of Notch signaling alters the phenotype of orthotopic tumors formed from glioblastoma multiforme neurosphere cells but does not hamper intracranial tumor growth regardless of endogene Notch pathway signature.Cancer Biol Ther2014;15:862-77

[75] Raghu H,Dinh DH,Rao JS.Specific knockdown of uPA/uPAR attenuates invasion in glioblastoma cells and xenografts by inhibition of cleavage and trafficking of Notch -1 receptor.Mol Cancer2011;10:130 PMCID:PMC3210098

[76] Jung E,Ratliff M.Tumor cell plasticity, heterogeneity, and resistance in crucial microenvironmental niches in glioma.Nat Commun2021;12:1014 PMCID:PMC7881116

[77] Audia A,Glass R.The impact of the tumor microenvironment on the properties of glioma stem-like cells.Front Oncol2017;7:143 PMCID:PMC5502267

[78] Peereboom DM,Mikkelsen T.A phase ii and pharmacodynamic trial of RO4929097 for patients with recurrent/progressive glioblastoma.Neurosurgery2021;88:246-51 PMCID:PMC7919338

[79] Xu R,Hovinga K.Molecular and clinical effects of notch inhibition in glioma patients: a phase 0/I trial.Clin Cancer Res2016;22:4786-96 PMCID:PMC5050072

[80] Lehal R,Vigolo M.Pharmacological disruption of the Notch transcription factor complex.Proc Natl Acad Sci U S A2020;117:16292-301 PMCID:PMC7368267

[81] Giordano F,Panno ML et al.A Notch inhibitor plus Resveratrol induced blockade of autophagy drives glioblastoma cell death by promoting a switch to apoptosis.Am J Cancer Res2021;11:5933-50 PMCID:PMC8727809

[82] Floyd DH,Seleverstov O.Alpha-secretase inhibition reduces human glioblastoma stem cell growth in vitro and in vivo by inhibiting Notch.Neuro Oncol2012;14:1215-26 PMCID:PMC3452340

[83] Chang SF,Cheng CY,Wang TC.γ-secretase inhibitors, DAPT and RO4929097, promote the migration of Human Glioma Cells via Smad5-downregulated E-cadherin Expression.Int J Med Sci2021;18:2551-60 PMCID:PMC8176174

[84] Nam DH,Kim S.Activation of notch signaling in a xenograft model of brain metastasis.Clin Cancer Res2008;14:4059-66

[85] Friedman GK,Nan L.Pediatric medulloblastoma xenografts including molecular subgroup 3 and CD133+ and CD15+ cells are sensitive to killing by oncolytic herpes simplex viruses.Neuro Oncol2016;18:227-35 PMCID:PMC4724175

[86] Teodorczyk M.Notching on cancer’s door: notch signaling in brain tumors.Front Oncol2014;4:341 PMCID:PMC4283135

[87] Olsauskas-Kuprys R,Osipo C.Gamma secretase inhibitors of Notch signaling.Onco Targets Ther2013;6:943-55 PMCID:PMC3726525

[88] Andersson ER.Therapeutic modulation of Notch signalling--are we there yet?.Nat Rev Drug Discov2014;13:357-78

[89] Gilbert CA,Moser RP.Gamma-secretase inhibitors enhance temozolomide treatment of human gliomas by inhibiting neurosphere repopulation and xenograft recurrence.Cancer Res2010;70:6870-9 PMCID:PMC2932884

[90] Dantas-Barbosa C,Daudigeos-Dubus E.Inhibition of the NOTCH pathway using γ-secretase inhibitor RO4929097 has limited antitumor activity in established glial tumors.Anticancer Drugs2015;26:272-83

[91] Yahyanejad S,Iglesias VS.NOTCH blockade combined with radiation therapy and temozolomide prolongs survival of orthotopic glioblastoma.Oncotarget2016;7:41251-64 PMCID:PMC5173056

[92] Hovinga KE,Wang R.Inhibition of notch signaling in glioblastoma targets cancer stem cells via an endothelial cell intermediate.Stem Cells2010;28:1019-29 PMCID:PMC5532884

[93] Staberg M,Olsen LS.Combined EGFR- and notch inhibition display additive inhibitory effect on glioblastoma cell viability and glioblastoma-induced endothelial cell sprouting in vitro.Cancer Cell Int2016;16:34 PMCID:PMC4845362

[94] Monticone M,Fabiano A.z-Leucinyl-leucinyl-norleucinal induces apoptosis of human glioblastoma tumor-initiating cells by proteasome inhibition and mitotic arrest response.Mol Cancer Res2009;7:1822-34

[95] Chu Q,Semenkow S,Eberhart CG.Prolonged inhibition of glioblastoma xenograft initiation and clonogenic growth following in vivo Notch blockade.Clin Cancer Res2013;19:3224-33 PMCID:PMC3686970

[96] Strosberg JR,Weber J.A phase II study of RO4929097 in metastatic colorectal cancer.Eur J Cancer2012;48:997-1003 PMCID:PMC4522922

[97] Pan E,Kaley TJ.Phase I study of RO4929097 with bevacizumab in patients with recurrent malignant glioma.J Neurooncol2016;130:571-9 PMCID:PMC5571739

[98] Wu Y,Choy L.Therapeutic antibody targeting of individual Notch receptors.Nature2010;464:1052-7

[99] Aste-Amézaga M,Lineberger JE.Characterization of Notch1 antibodies that inhibit signaling of both normal and mutated Notch1 receptors.PLoS One2010;5:e9094 PMCID:PMC2817004

[100] Herrera-Rios D,Khan D.A computational guided, functional validation of a novel therapeutic antibody proposes Notch signaling as a clinical relevant and druggable target in glioma.Sci Rep2020;10:16218 PMCID:PMC7531005

[101] Noguera-Troise I,Papadopoulos NJ.Blockade of Dll4 inhibits tumour growth by promoting non-productive angiogenesis.Nature2006;444:1032-7

[102] Li JL,Shi W.Delta-like 4 Notch ligand regulates tumor angiogenesis, improves tumor vascular function, and promotes tumor growth in vivo.Cancer Res2007;67:11244-53

[103] Conte A,Procaccini C.Convergent effects of resveratrol and PYK2 on prostate cells.Int J Mol Sci2016;17:1542 PMCID:PMC5037816

[104] Amicis F, Chimento A, Montalto FI, Casaburi I, Sirianni R, Pezzi V. Steroid receptor signallings as targets for resveratrol actions in breast and prostate cancer.Int J Mol Sci2019;20:1087 PMCID:PMC6429419

[105] Ko JH,Um JY.The role of resveratrol in cancer therapy.Int J Mol Sci2017;18:2589 PMCID:PMC5751192

[106] Lin H,Zhang X.Notch-1 activation-dependent p53 restoration contributes to resveratrol-induced apoptosis in glioblastoma cells.Oncol Rep2011;26:925-30

[107] Wang J,Liu X,Wang C.Alpinetin targets glioma stem cells by suppressing Notch pathway.Tumour Biol2016;37:9243-8

[108] Khathayer F.Diosgenin as a novel alternative therapy for inhibition of growth, invasion, and angiogenesis abilities of different glioblastoma cell lines.Neurochem Res2020;45:2336-51

[109] Kim TJ,Kang M,Lee KH.The antitumor natural compound falcarindiol disrupts neural stem cell homeostasis by suppressing notch pathway.Int J Mol Sci2018;19:3432 PMCID:PMC6274977

[110] Wieland A,Gogolok S.Anticancer effects of niclosamide in human glioblastoma.Clin Cancer Res2013;19:4124-36

[111] Opačak-Bernardi T,Raucher D.Effects of cell penetrating Notch inhibitory peptide conjugated to elastin-like polypeptide on glioblastoma cells.J Drug Target2017;25:523-31